ConductScience.org, home

Paper23242597

The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome.

Costantini B and 9 others. Haematologica, 2013. Cited by 96 papers, by iCite.

Cite this record

ConductScience Library. The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome. Papers, record 23242597. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23242597

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome.
PubMed
Journal
Haematologica
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
96
iCite
Relative citation ratio, by iCite
2.26
iCite
Revised in PubMed
2025-05-29
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Costantini BBenedetta
2Kordasti SYShahram Y
3Kulasekararaj AGAustin G
4Jiang JJie
5Seidl TThomas
6Abellan PPPilar Perez
7Mohamedali AAzim
8Thomas NSNicolas Shaun B
9Farzaneh FFarzin
10Mufti GJGhulam J

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AzacitidineMajor topic
Myelodysplastic SyndromesMajor topic
T-Lymphocytes, RegulatoryMajor topic
Adult
Aged
Aged, 80 and over
Female
Follow-Up Studies
Humans
Lymphocyte Count
Male
Middle Aged
Th1 Cells
Th17 Cells
Th2 Cells
Treatment Outcome

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
MR/J006742/1Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117611569CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine.Leukemia2007https://conductscience.org/library/papers/17611569PubMed
28943243The proximal regulatory element of the interferon-gamma promoter mediates selective expression in T cells.J Biol Chem1996https://conductscience.org/library/papers/8943243PubMed
321098230IL-17- and IFN-γ-secreting Foxp3+ T cells infiltrate the target tissue in experimental autoimmunity.J Immunol2010https://conductscience.org/library/papers/21098230PubMed
419151746Epigenetic control of T-helper-cell differentiation.Nat Rev Immunol2009https://conductscience.org/library/papers/19151746PubMed
58551029Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies.J Immunol Methods1995https://conductscience.org/library/papers/8551029PubMed
619887673Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting.Blood2010https://conductscience.org/library/papers/19887673PubMed
719230772Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.Lancet Oncol2009https://conductscience.org/library/papers/19230772PubMed
818566595How regulatory T cells work.Nat Rev Immunol2008https://conductscience.org/library/papers/18566595PubMed
917412885CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS).Blood2007https://conductscience.org/library/papers/17412885PubMed
107527544Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/7527544PubMed
1116707479DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukemia.Cancer Res2006https://conductscience.org/library/papers/16707479PubMed
1216952911Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets.Carcinogenesis2006https://conductscience.org/library/papers/16952911PubMed
1319389880A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.Blood2009https://conductscience.org/library/papers/19389880PubMed
1417591856CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation.J Exp Med2007https://conductscience.org/library/papers/17591856PubMed
1522555974Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer.Blood2012https://conductscience.org/library/papers/22555974PubMed
1621493801Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells.Blood2011https://conductscience.org/library/papers/21493801PubMed
1718206726Hypomethylation and apoptosis in 5-azacytidine-treated myeloid cells.Exp Hematol2008https://conductscience.org/library/papers/18206726PubMed
1812495905DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias.Haematologica2002https://conductscience.org/library/papers/12495905PubMed
1921435589CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model.Immunity2011https://conductscience.org/library/papers/21435589PubMed
2017998812Reactivation of epigenetically silenced genes by DNA methyltransferase inhibitors: basic concepts and clinical applications.Epigenetics2006https://conductscience.org/library/papers/17998812PubMed

See all 44 referencesDownload CSV of references

Cited by71

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.

PMIDTitleJournalYearIn PapersSource
42558501Hypomethylating agents are the current therapy backbone for MDS and AML relapsing after allogeneic hematopoietic stem cell transplantation.Front Immunol2026https://conductscience.org/library/papers/42558501PubMed
42367853Azacytidine restores T cell function in AML by modulating DNA methylation.bioRxiv2026https://conductscience.org/library/papers/42367853PubMed
42279389Myeloid Malignancies Beyond the Cell: Targeting the Tumour Microenvironment with Next-Generation Immunotherapies.Cancers (Basel)2026https://conductscience.org/library/papers/42279389PubMed
41531276Hypomethylating agents in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS): A systematic review.Br J Haematol2026https://conductscience.org/library/papers/41531276PubMed
40675972Humanized mouse models in MDS.Cell Death Dis2025https://conductscience.org/library/papers/40675972PubMed
40473616
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence.
Nat Commun2025https://conductscience.org/library/papers/40473616PubMed
40038722The epigenetic hallmarks of immune cells in cancer.Mol Cancer2025https://conductscience.org/library/papers/40038722PubMed
39949137[Pathogenesis and treatment progression of myelodysplastic syndrome combined with Behçet's syndrome].Zhejiang Da Xue Xue Bao Yi Xue Ban2025https://conductscience.org/library/papers/39949137PubMed
39594638Understanding Myelodysplasia and Inflammation Through the Lense of VEXAS Syndrome: A Review.Cells2024https://conductscience.org/library/papers/39594638PubMed
39485042Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine.Cancer Res Commun2024https://conductscience.org/library/papers/39485042PubMed
39376992Molecular profiling of pre- and post- 5-azacytidine myelodysplastic syndrome samples identifies predictors of response.Front Oncol2024https://conductscience.org/library/papers/39376992PubMed
39287751Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia.Discov Oncol2024https://conductscience.org/library/papers/39287751PubMed
39030997Phase 1 dose escalation study of the MDM2 inhibitor milademetan as monotherapy and in combination with azacitidine in patients with myeloid malignancies.Cancer Med2024https://conductscience.org/library/papers/39030997PubMed
38917523The DNA methylation landscape across the TCR loci in patients with acute myeloid leukemia.Int Immunopharmacol2024https://conductscience.org/library/papers/38917523PubMed
38840907Case report: VEXAS syndrome: an atypical indolent presentation as sacroiliitis with molecular response to azacitidine.Front Immunol2024https://conductscience.org/library/papers/38840907PubMed
38044445Targeting the epigenome to reinvigorate T cells for cancer immunotherapy.Mil Med Res2023https://conductscience.org/library/papers/38044445PubMed
38003240HCV and HCC Tango-Deciphering the Intricate Dance of Disease: A Review Article.Int J Mol Sci2023https://conductscience.org/library/papers/38003240PubMed
37809078Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy.Front Immunol2023https://conductscience.org/library/papers/37809078PubMed
37501758VEXAS Syndrome-Review.Glob Med Genet2023https://conductscience.org/library/papers/37501758PubMed
37217462Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37217462PubMed

See all 71 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23242597

GET https://conductscience.org/api/papers/v1/23242597/references?page=2